Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer

Clinical trial NCT00506623 · UNKNOWN

Trial details

NCT number: NCT00506623
Sponsor: National Cancer Center, Korea
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Neoplasm Neoadjuvant Therapy

Start date: 2004-07-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.